1. Home
  2. RR vs RGNX Comparison

RR vs RGNX Comparison

Compare RR & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$1.92

Market Cap

483.0M

Sector

N/A

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.80

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
RGNX
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.0M
418.1M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
RR
RGNX
Price
$1.92
$8.80
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$4.00
$28.75
AVG Volume (30 Days)
6.7M
657.4K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
$5,045,000.00
$10,393,000.00
Revenue This Year
$75.68
$50.05
Revenue Next Year
$78.28
$23.31
P/E Ratio
N/A
N/A
Revenue Growth
18.99
126.48
52 Week Low
$1.69
$5.04
52 Week High
$7.43
$16.19

Technical Indicators

Market Signals
Indicator
RR
RGNX
Relative Strength Index (RSI) 34.57 50.26
Support Level $1.81 $8.68
Resistance Level $2.04 $9.28
Average True Range (ATR) 0.14 0.49
MACD 0.02 0.13
Stochastic Oscillator 11.00 78.52

Price Performance

Historical Comparison
RR
RGNX

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: